Gland Pharma Ltd
NSE:GLAND
Gland Pharma Ltd
NSE:GLAND
Price:
1 469.4
INR
0.62%
Market Closed
Market Cap:
242.1B
INR
Income Statement
Earnings Waterfall
Gland Pharma Ltd
Gland Pharma Ltd
|
Revenue
|
57.3B
INR
|
|
Cost of Revenue
|
-22B
INR
|
|
Gross Profit
|
35.3B
INR
|
|
Operating Expenses
|
-26.2B
INR
|
|
Operating Income
|
9.1B
INR
|
|
Other Expenses
|
-2B
INR
|
|
Net Income
|
7B
INR
|
Income Statement
Gland Pharma Ltd
Gland Pharma Ltd
Currency: INR
Millions
TTM
| Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||
| Revenue |
41 634
N/A
|
49 949
+20%
|
52 084
+4%
|
34 629
-34%
|
37 326
+8%
|
39 815
+7%
|
41 854
+5%
|
44 007
+5%
|
41 037
-7%
|
40 676
-1%
|
39 426
-3%
|
36 246
-8%
|
39 764
+10%
|
43 054
+8%
|
49 123
+14%
|
56 647
+15%
|
58 577
+3%
|
58 901
+1%
|
57 290
-3%
|
|
| Gross Profit | ||||||||||||||||||||
| Cost of Revenue |
(17 452)
|
(21 187)
|
(22 481)
|
(15 382)
|
(17 084)
|
(18 589)
|
(19 555)
|
(21 493)
|
(19 468)
|
(19 422)
|
(18 659)
|
(17 333)
|
(17 643)
|
(17 664)
|
(19 385)
|
(22 313)
|
(22 844)
|
(23 383)
|
(22 018)
|
|
| Gross Profit |
24 182
N/A
|
28 762
+19%
|
29 603
+3%
|
19 247
-35%
|
20 242
+5%
|
21 226
+5%
|
22 300
+5%
|
22 514
+1%
|
21 569
-4%
|
21 254
-1%
|
20 767
-2%
|
18 913
-9%
|
22 121
+17%
|
25 390
+15%
|
29 737
+17%
|
34 334
+15%
|
35 733
+4%
|
35 518
-1%
|
35 272
-1%
|
|
| Operating Income | ||||||||||||||||||||
| Operating Expenses |
(9 814)
|
(11 664)
|
(11 987)
|
(7 213)
|
(7 981)
|
(8 191)
|
(8 446)
|
(8 513)
|
(9 327)
|
(9 915)
|
(10 119)
|
(10 068)
|
(13 405)
|
(16 848)
|
(21 204)
|
(24 449)
|
(26 410)
|
(26 591)
|
(26 219)
|
|
| Selling, General & Administrative |
(7 347)
|
(8 325)
|
(8 468)
|
(5 902)
|
(3 996)
|
(4 077)
|
(4 118)
|
(6 946)
|
(4 628)
|
(4 903)
|
(5 150)
|
(8 100)
|
(7 008)
|
(9 307)
|
(12 097)
|
(20 129)
|
(15 841)
|
(15 961)
|
(15 842)
|
|
| Research & Development |
(296)
|
0
|
0
|
(322)
|
0
|
0
|
0
|
(427)
|
0
|
0
|
0
|
(404)
|
0
|
0
|
0
|
(320)
|
0
|
0
|
0
|
|
| Depreciation & Amortization |
(1 430)
|
(1 677)
|
(1 684)
|
(988)
|
(998)
|
(1 013)
|
(1 041)
|
(1 103)
|
(1 199)
|
(1 305)
|
(1 403)
|
(1 467)
|
(1 771)
|
(2 218)
|
(2 895)
|
(3 446)
|
(3 712)
|
(3 837)
|
(3 747)
|
|
| Other Operating Expenses |
(740)
|
(1 662)
|
(1 834)
|
(1)
|
(2 986)
|
(3 101)
|
(3 287)
|
(38)
|
(3 500)
|
(3 707)
|
(3 566)
|
(97)
|
(4 625)
|
(5 323)
|
(6 212)
|
(554)
|
(6 856)
|
(6 792)
|
(6 629)
|
|
| Operating Income |
14 368
N/A
|
17 099
+19%
|
17 616
+3%
|
12 034
-32%
|
12 261
+2%
|
13 035
+6%
|
13 853
+6%
|
14 000
+1%
|
12 242
-13%
|
11 339
-7%
|
10 648
-6%
|
8 844
-17%
|
8 717
-1%
|
8 543
-2%
|
8 533
0%
|
9 885
+16%
|
9 323
-6%
|
8 928
-4%
|
9 053
+1%
|
|
| Pre-Tax Income | ||||||||||||||||||||
| Interest Income Expense |
1 377
|
1 370
|
1 415
|
1 236
|
(19)
|
(22)
|
(22)
|
2 189
|
(51)
|
(58)
|
(73)
|
2 331
|
(115)
|
(158)
|
(184)
|
1 469
|
(269)
|
(270)
|
(445)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(628)
|
(565)
|
(565)
|
(565)
|
0
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
174
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
|
| Total Other Income |
281
|
658
|
757
|
78
|
1 625
|
1 933
|
2 039
|
(2)
|
2 364
|
2 508
|
2 667
|
(1)
|
2 036
|
1 911
|
1 670
|
(31)
|
1 841
|
1 906
|
2 117
|
|
| Pre-Tax Income |
16 200
N/A
|
19 126
+18%
|
19 787
+3%
|
13 348
-33%
|
13 867
+4%
|
14 947
+8%
|
15 870
+6%
|
16 186
+2%
|
14 555
-10%
|
13 789
-5%
|
13 242
-4%
|
10 546
-20%
|
10 073
-4%
|
9 732
-3%
|
9 455
-3%
|
11 325
+20%
|
10 895
-4%
|
10 564
-3%
|
10 726
+2%
|
|
| Net Income | ||||||||||||||||||||
| Tax Provision |
(3 795)
|
(4 532)
|
(4 693)
|
(3 378)
|
(3 526)
|
(3 774)
|
(4 008)
|
(4 069)
|
(3 650)
|
(3 493)
|
(3 357)
|
(2 735)
|
(2 614)
|
(2 743)
|
(2 867)
|
(3 601)
|
(3 674)
|
(3 648)
|
(3 682)
|
|
| Income from Continuing Operations |
12 405
|
14 594
|
15 094
|
9 970
|
10 340
|
11 173
|
11 862
|
12 117
|
10 905
|
10 296
|
9 885
|
7 810
|
7 460
|
6 988
|
6 587
|
7 725
|
7 221
|
6 916
|
7 044
|
|
| Net Income (Common) |
12 405
N/A
|
14 594
+18%
|
15 094
+3%
|
9 970
-34%
|
7 736
-22%
|
8 568
+11%
|
9 258
+8%
|
12 117
+31%
|
10 905
-10%
|
10 296
-6%
|
9 885
-4%
|
7 810
-21%
|
7 460
-4%
|
6 988
-6%
|
6 587
-6%
|
7 725
+17%
|
7 221
-7%
|
6 916
-4%
|
7 044
+2%
|
|
| EPS (Diluted) |
75.96
N/A
|
94.15
+24%
|
94.81
+1%
|
62.99
-34%
|
47.14
-25%
|
52.1
+11%
|
56.35
+8%
|
73.64
+31%
|
66.24
-10%
|
62.52
-6%
|
60
-4%
|
47.43
-21%
|
45.28
-5%
|
42.41
-6%
|
39.98
-6%
|
46.89
+17%
|
43.83
-7%
|
41.98
-4%
|
42.75
+2%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
